We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

20 hedge funds and large institutions have $139M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more capital invested

Capital invested by funds: $60.8M → $139M (+$78.4M)

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

25% more funds holding

Funds holding: 1620 (+4)

0.01% more ownership

Funds ownership: 6%6% (+0.01%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
4
Reduced
5
Closed
5
Calls
Puts
Net Calls
Net Calls Change

NBP Hedge Fund Activity: Q2 2020 in Review

20 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q2 2020, worth a combined $139M — up 129% from $60.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new NBP positions and 5 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Snow Lake Capital, adding an estimated $3M. The largest seller was Sio Capital Management, cutting an estimated $7.33M.

  • 20 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q2 2020, up from 16 in Q1 2020.
  • Funds reported $139M of NovaBridge Biosciences American Depositary Shares stock for Q2 2020, up 129% quarter-over-quarter.
  • 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q2 2020 and 5 closed out, a net change of +4 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q2 2020 was Snow Lake Capital, an estimated $3M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q2 2020 was Sio Capital Management, an estimated $7.33M sold.

Based on aggregated 13F filings for Q2 2020.